Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Jan 29, 2010

Corning and Sartorius Stedim Biotech to Provide Combined Cell-Culture Product Catalog

  • Corning and Sartorius Stedim Biotech will co-market a range of cell-culture products through a combined product catalog and will work together on numerous marketing and sales initiatives. The companies also are exploring best options and approaches for future R&D efforts and joint product development.

    A combined cell-culture product catalog for North America is already available, with additional regional catalogs to follow soon, the firms note.

    “As competitive pressures in the cell-culture industry continue to evolve and increase, it is critical that we are able to offer customers a full range of cell-culture laboratory products spanning basic research to full-scale production,” says Thomas Appelt, vp and GM, Corning Life Sciences.

    The collaboration will build off the companies’ existing relationship and will take effect immediately.

     



Related content

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »